Deep Phenotypic Characterization of NY-ESO TCR Engineered T Cells and Tumor in Patients With Advanced Myeloma
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p295
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2015
Authors
Publisher
BMJ